Fund
Ljungström family office
Ljungström family office led the round of AnaCardio (62,5 M€, Series B) on 30 September 2026. 2 health rounds logged by Bolus since September 2026, 1 of them as lead.
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 2
- Lead
- 1
- New entries
- 1
- Follow ons
- 0
- Latest operation
- 30 September 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 30 Sept | Sweden, Biotech | Series B | 62,5 M€ | Lead |
| 29 Sept | Denmark, Biotech | Series A | 67,5 M€ | Participant |
Co investors 13 funds crossed
- Innovestor Life Science 2 operations
- Novo Holdings 2 operations
- Sound Bioventures 2 operations
- Catalyze Capital 1 operation
- EIFO 1 operation
- Flerie 1 operation
- Helsinn 1 operation
- Industrifonden 1 operation
- LLD Nybohov Invest AB 1 operation
- Mission BioCapital 1 operation
- Modi Ventures 1 operation
- Pappas Capital 1 operation
- Pureos Bioventures 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: Sweden, Denmark.